At Cedorex we focus on products that protect and enhance people’s lives. Our portfolio consists of both proprietary and in-licensed products.

We are accelerating the discovery and development of next-generation monoclonal antibody therapies and biosimilar biologics for emerging markets.

Biopharmaceutical therapies are precious for public health. We are committed to following sound scientific principles and regulatory standards. Quality is at the cornerstone of all that we do.

Cedorex continues to invest into public awareness in oncology, diabetes and cardiovascular diseases.